Fatality from administration of labetalol and crushed extended-release nifedipine.
about
Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safetyImpact of a warning CPOE system on the inappropriate pill splitting of prescribed medications in outpatientsSubstantial reduction of inappropriate tablet splitting with computerised decision support: a prospective intervention study assessing potential benefit and harm.Curse of the ghost pills: the role of oral controlled-release formulations in the passage of empty intact shells in faeces. Two case reports and a literature review relevant to psychiatry.Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.Association between physician specialty and risk of prescribing inappropriate pill splitting.Older adults with difficulty swallowing oral medicines: a systematic review of the literature.Dose form modification - a common but potentially hazardous practice. A literature review and study of medication administration to older psychiatric inpatients.Oral drug therapy in elderly with dysphagia: between a rock and a hard place!Therapeutic concerns when oral medications are administered nasogastrically.Misuse of the Naranjo Adverse Drug Reaction Probability Scale in toxicology.Clinical nutrition and drug interactions.Challenges in oral drug delivery in patients with esophageal dysphagia.ASPEN Safe Practices for Enteral Nutrition Therapy [Formula: see text].Analysis of drug use in institutionalized individuals with intellectual disability and tube feeding.More than just crushing: a prospective pre-post intervention study to reduce drug preparation errors in patients with feeding tubes.Quality improvement of oral medication administration in patients with enteral feeding tubes.Appropriateness of administration of nasogastric medication and preliminary intervention.Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms.Medicine administration errors in patients with dysphagia in secondary care: a multi-centre observational study.Oral medicine modification for older adults: a qualitative study of nurses.Assessment of drug administration via feeding tube and the knowledge of health-care professionals in a university hospital.Drug administration via enteral feeding tubes in residential care facilities for individuals with intellectual disability: an observational study.Drug administration via enteral feeding tube in residential care facilities for individuals with intellectual disability: A focus group study on guideline implementation.Impact of recommendations on crushing medications in geriatrics: from prescription to administration.Development and evaluation of an algorithm to facilitate drug prescription for inpatients with feeding tubes.Inappropriate crushing information on ward lists: cytotoxic drugs, capsules, and modified release formulations are gravely neglected.The role of clinical pharmacist to improve medication administration through enteral feeding tubes by nurses.
P2860
Q21202050-84FCA834-6490-4F25-AF97-BBDDA73575B6Q28542540-E5C57921-882C-4DD7-ACC4-AC34F30D6B73Q33467067-C4987C9F-6AB4-4649-BE25-4462B8C5B4C0Q33949355-07DCF216-D7ED-4428-A0FF-F786519390CBQ34410837-CA549615-C09D-42A8-BE93-F2BA03EF8C8BQ34905932-81F2245D-54B0-474E-A9E5-8B9C3EE1B6F4Q35843051-08FC5A67-2E8A-4DC6-A3EB-FDFDECA09727Q36915559-7FBA873F-CA0F-458F-9A11-B07DC31984EAQ37626330-55304DC6-F613-48CB-ACFF-4F0ACD7F485FQ38100265-3D6B200D-D0EB-4C1A-AC78-F16527191E57Q38115343-79B4D3B2-EB54-4DCE-BE07-D3F0F8920171Q38452925-A43F8C04-184C-431E-8EC7-D80BE51545E5Q38701531-CA9D1A37-2B62-4A3A-9553-8C62CD8DE2C0Q38999196-4C7FAA29-AE6D-4D42-BE76-ED9B21C1E289Q39852900-ADB35C50-F621-4A75-9801-9476EFD12FA4Q41473670-6BE1CBCF-07E3-45FE-A1AD-4439241608F0Q42042901-1A517561-9F71-4C47-8591-D4E34122A6C8Q42055284-24A3009F-4579-4B71-B92D-09EEC266713DQ44724914-540BC7F3-AE2B-4D4A-9089-464C7013EF27Q45023336-3FB49610-0093-49FA-BDB0-094BE3578C7BQ47160794-D3812449-42F8-437E-9E88-FEB09C6A0EC8Q47719043-6D12604B-CA79-4E8F-A459-239CD02EE08AQ49073688-077690F2-CCB1-425A-BA8C-0D788A0B91F4Q49107953-2F6A34A8-6A70-4B8A-899D-9D303BE7CE72Q50577383-0F0C39E5-A3AA-473E-8407-A39D9664982AQ50584757-EA46FF8C-CB95-433F-861A-358BBD28EFD9Q50728869-324965CF-FE1E-473D-8245-AC3EFB99EADAQ50928399-B239707C-3FCC-4A9B-8658-930571504734
P2860
Fatality from administration of labetalol and crushed extended-release nifedipine.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Fatality from administration of labetalol and crushed extended-release nifedipine.
@en
Fatality from administration of labetalol and crushed extended-release nifedipine.
@nl
type
label
Fatality from administration of labetalol and crushed extended-release nifedipine.
@en
Fatality from administration of labetalol and crushed extended-release nifedipine.
@nl
prefLabel
Fatality from administration of labetalol and crushed extended-release nifedipine.
@en
Fatality from administration of labetalol and crushed extended-release nifedipine.
@nl
P2860
P356
P1476
Fatality from administration of labetalol and crushed extended-release nifedipine.
@en
P2093
Joshua G Schier
Mary Ann Howland
P2860
P304
P356
10.1345/APH.1D091
P407
P577
2003-10-01T00:00:00Z